EMA‐EP regimen, as firstline multiple agent chemotherapy in high‐risk GTT patients (stage II–IV) von Ghaemmaghami, F., Modares, M., Arab, M., Behtash, N., Moosavi, A. Z., Khanafshar, N., Hanjani, P.

Volltext

Simple hysterectomy in the presence of invasive cervical cancer in Iran von Behtash, N., Mousavi, A., Mohit, M., Modares, M., Khanafshar, N., Hanjani, P.

Volltext

Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature von Behtash, Nadereh, Mousavi, Azam, Tehranian, Afsaneh, Khanafshar, Navid, Hanjani, Parviz

Volltext

First-line chemotherapy with 5-FU and platinum for advanced and recurrent cancer of the cervix: a Phase II study von GHAEMMAGHAMI, F, BEHTASH, N, YARANDI, F, MOOSAVI, A, MODARES, M, TOOGEH, G, KHANAFSHAR, N

Volltext

EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II-IV) von GHAEMMAGHAMI, F., MODARES, M., ARAB, M., BEHTASH, N., MOOSAVI, A.Z., KHANAFSHAR, N., HANJANI, P.

Volltext

Simple hysterectomy in the presence of invasive cervical cancer in Iran von Behtash, N., Mousavi, A., Mohit, M., Modares, M., Khanafshar, N., Hanjani, P.

Volltext

Neonatal Hypothermia In Tehran, Iran: Incidence, Severity And Death Rate von F. Nayeri, F. Nili, E. Amini, N. Khanafshar, F. Zayeri, P. Palizian, M. Delfan

Volltext

Surveying of relationship between anxiety, depression and duration of infertility von Ramezanzadeh, Fatemeh, Aghssa, M.M., Abedinia, N., Zayeri, F., Khanafshar, N., Jafarabadi, M.

Volltext

Hypothermia in iranian newborns : Incidence, risk factors and related complications von ZAYERI, Farid, KAZEMNEJAD, Anoshirvan, GANJALI, Mojtaba, BABAEI, Gholamreza, KHANAFSHAR, Navid, NAYERI, Fatemeh

Volltext

Cutaneous Metastasis from Carcinoma of the Cervix at the Drain Site von Behtash, Nadereh, Ghaemmaghami, Fatemeh, Yarandi, Fariba, Ardalan, Farid Azmodeh, Khanafshar, Navid

Volltext

The effect of HMG and recombinant human FSH on oocyte quality: a randomized single-blind clinical trial von Rashidi, Batool Hossein, Sarvi, Fatemeh, Tehrani, Ensieh Shahrokh, Zayeri, Farid, Movahedin, Mansoureh, Khanafshar, Navid

Volltext

A pilot study of first-line chemotherapy with 5-FU and Platinum in advanced and recurrent cancer of the cervix von Ghaemmaghami F, Behtash N, Yarandi F, Moosavi A, Toogeh Gh.R, Khanafshar N

Volltext

A pilot study of first-line chemotherapy with 5-FU and Platinum in advanced and recurrent cancer of the cervix von Ghaemmaghami F, Behtash N, Yarandi F, Moosavi A, Toogeh Gh.R, Khanafshar N

Volltext

Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management von Chiosea, Simion, Hodak, Steven P, Yip, Linwah, Abraham, Devaprabu, Baldwin, Chelsey, Baloch, Zubair, Gulec, Seza A, Hannoush, Zeina C, Haugen, Bryan R, Joseph, Lija, Kargi, Atil Y, Khanafshar, Elham, Livhits, Masha J, McIver, Bryan, Patel, Kepal, Patel, Snehal G, Randolph, Gregory W, Shaha, Ashok R, Sharma, Jyotirmay, Stathatos, Nikolaos, van Zante, Annemieke, Carty, Sally E, Nikiforov, Yuri E, Nikiforova, Marina N

Volltext

Phase I Dose-Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy in Patients With Human Epidermal Growth Factor Receptor 2―Overexpressing Breast Cancer von CHIEN, A. Jo, MUNSTER, Pamela N, MOASSER, Mark M, MELISKO, Michelle E, RUGO, Hope S, PARK, John W, GOGA, Andrei, AUERBACK, Glenna, KHANAFSHAR, Elham, ORDOVAS, Karen, KOCH, Kevin M

Volltext

A phase I dose and exposure escalation study of 5-day intermittent oral lapatinib (Lp) therapy in patients with HER2-overexpressing breast cancer (BC) von Chien, A. J., Koch, K., Auerback, G., Rugo, H. S., Melisko, M. E., Park, J. W., Khanafshar, E., Ordovas, K., Munster, P. N., Moasser, M. M.

Volltext

15TH INTERNATIONAL THYROID CONGRESS PROGRAM AND MEETING ABSTRACTS von Korevaar, T.I., Ricarte-Filho, J.C., Al-Rijjala, R., Kim, E., Endert, E., da Silva, M.R. Dias, Tala, H., Kim, H., Ricardo, L., Ookouchi, C., Demartino, G., Song, R., Goldberg, I., Watkins, R., Klein-Hitpass, L., Adelstein, S., McMillan, M.S., Cardenas-Gomez, M., Oliveira, T.L., Gomes, L.S., Ehrenkranz, J., Montanelli, L., Kumar, S., Pappalardo, V., Inversini, D., Portari, L.C., Kellokumpu-Lehtinen, P., Atzori, F., Raffeld, M., Plazarte, M., Tran, C., Liu, Z., Schneider, D., Yamaguchi, I., Suzuki, A., Grubbs, E., Ohori, P., Liu, Z., Calbo, L., Grey, J., Liu, W., Kim, W., Alsina, M.E. Sevilla, Zhang, X., Almeida, N.A., Kulyash, A., Fedotov, Y., De Ycaza, A.E. Espinosa, Lopes, L., Oh, S., Souza, V.P., Miguel, J.P., Vlahov, J., Lee, J., Blidner, A., Zwanziger, D., Kebebew, E., Roy, N., Ito, Y., Tuccari, G., Rocha, G., Munoz, A.J., Joglekar, S., Lei, J., Watt, T., Andersen, S., Wang, X., Gaurang, A., Camargo, R.Y., Jiang, F.W., Morino, M., Masini-Repiso, A.M., Gutierrez, H., Bošković, O., Kim, W., Bocca, G., van der Pal, H.J., Cipri, C., Pereira, M.A., Wadsley, J., Wang, T.S., Kim, S., Plantinga, T.S., Peres, K.C., Miasaki, F.Y., Bottici, V., Lanni, A., Bianchini, A., Bianchini, A.L., Giorgi, F., Vieira, J.G., Sinclair, B., Kim, I., Bissen, L., Sacks, W.L., Wong, R., Al-Qurayshi, Z., Stafford, L.M. Cherney, Feodoridis, Y., Borrebach, J.

Volltext

A phase I dose-escalation study of 5-day intermittent oral lapatinib therapy with biomarker analysis in patients with HER-2–overexpressing breast cancer von Chien, A. J., Auerback, G., Rugo, H. S., Melisko, M., Munster, P. N., Khanafshar, E., Ordovas, K. G., Petricoin, E. F., Koch, K. M., Moasser, M. M.

Volltext